OR WAIT null SECS
November 18, 2010
Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.
November 17, 2010
To find out about the regulatory, formulation, and manufacturing considerations involved in developing a new device to deliver a drug, Equipment and Processing Report talked to Paul Wotton, CEO of Antares Pharma.
November 11, 2010
Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More
November 04, 2010
sanofi acquires BMP Sunstone; DCAT Names President; and More.
November 02, 2010
Editors' picks of pharmaceutical science and technology innovations.
Abuse-deterrent combination drugs represent a niche area in formulation development.
As technology advances, industry's needs are growing.
The authors describe the development of an inclusion complex of GLZ and formulated an extended-release dosage form based on osmotic technology.
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.
Connecting science and policy might increase support for innovation.